Caricamento...
179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center
Salvato in:
| Pubblicato in: | J Thorac Oncol |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
International Association for the Study of Lung Cancer. Published by Elsevier Inc. Published by Elsevier Inc.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7997779/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1556-0864(21)02021-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|